Form 4 for PHAT Phathom Pharmaceuticals, Inc.
Accepted 2026-01-15 00:00:00 ET · period of report 2026-01-13 · accession 0001193125-26-014187 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-15 | 2026-01-13 | PHAT | Parikh Asit | Dir | M - OptEx | $10.30 | +8,750 | 131.0K | +7% | +$90.1K |
| D | 2026-01-15 | 2026-01-13 | PHAT | Parikh Asit | Dir | M - OptEx | $0.00 | -8,750 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-13 | M | A | 8,750 | $10.30 | 131,000 | D | — | — | |
| 2 | Derivative | Common Stock (Right to Buy) | 2026-01-13 | M | D | 8,750 | $0.00 | 0 | D | $10.30 · 2025-05-23 to 2034-05-22 | 8,750 Common Stock |